Compare AUR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AUR | BAX |
|---|---|---|
| Founded | 2017 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5B | 13.9B |
| IPO Year | 2021 | 1994 |
| Metric | AUR | BAX |
|---|---|---|
| Price | $6.31 | $26.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 9 |
| Target Price | $9.43 | ★ $21.00 |
| AVG Volume (30 Days) | ★ 27.8M | 7.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 4.35 | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $3,000,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $407.30 | $1.96 |
| Revenue Next Year | $1,134.58 | $2.22 |
| P/E Ratio | ★ N/A | $125.76 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $3.60 | $15.73 |
| 52 Week High | $8.57 | $30.00 |
| Indicator | AUR | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 55.15 |
| Support Level | $5.78 | $18.31 |
| Resistance Level | $6.75 | $30.00 |
| Average True Range (ATR) | 0.35 | 0.83 |
| MACD | -0.08 | -0.29 |
| Stochastic Oscillator | 24.06 | 16.19 |
Aurora Innovation is a US autonomous driving provider for heavy trucks. The company produces and sells its Aurora Driver system, which includes hardware installed in a vehicle, software to autonomously drive it, and data management to maintain and improve the software. Aurora targets long-haul routes. The company currently offers its trucking-as-a-service model, where it owns and operates the trucks and makes deliveries for customers. The company plans to start selling its driver-as-a-service model next year, where fleet owners will own the trucks and Aurora's software will operate them.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.